Cholesterol binding to ion channels by Irena Levitan et al.
REVIEW ARTICLE
published: 26 February 2014
doi: 10.3389/fphys.2014.00065
Cholesterol binding to ion channels
Irena Levitan*, Dev K. Singh and Avia Rosenhouse-Dantsker
Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
Edited by:
Harley T. Kurata, University of British
Columbia, Canada
Reviewed by:
Michael P. Blanton, Texas Tech
University Health Sciences Center,
USA
Jesus Perez-Gil, Universidad
Complutense de Madrid, Spain
*Correspondence:
Irena Levitan, Division of Pulmonary,
Critical Care, Sleep, and Allergy,
Department of Medicine, University
of Illinois at Chicago, 840 South
Wood Street (Room 920-N CSB),
Chicago, IL 60612-7323, USA
e-mail: levitan@uic.edu
Numerous studies demonstrated that membrane cholesterol is a major regulator of ion
channel function. The goal of this review is to discuss significant advances that have been
recently achieved in elucidating the mechanisms responsible for cholesterol regulation
of ion channels. The first major insight that comes from growing number of studies
that based on the sterol specificity of cholesterol effects, show that several types of
ion channels (nAChR, Kir, BK, TRPV) are regulated by specific sterol-protein interactions.
This conclusion is supported by demonstrating direct saturable binding of cholesterol
to a bacterial Kir channel. The second major advance in the field is the identification of
putative cholesterol binding sites in several types of ion channels. These include sites at
locations associated with the well-known cholesterol binding motif CRAC and its reversed
form CARC in nAChR, BK, and TRPV, as well as novel cholesterol binding regions in Kir
channels. Notably, in the majority of these channels, cholesterol is suggested to interact
mainly with hydrophobic residues in non-annular regions of the channels being embedded
in between transmembrane protein helices. We also discuss how identification of putative
cholesterol binding sites is an essential step to understand the mechanistic basis of
cholesterol-induced channel regulation. Clearly, however, these are only the first few steps
in obtaining a general understanding of cholesterol-ion channels interactions and their roles
in cellular and organ functions.
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INTRODUCTION: CHOLESTEROL REGULATION OF ION
CHANNELS
Cholesterol is one of the major lipid components of the plasma
membrane of most euakaryotic cells constituting 10–45mol%
with respect to other lipids (Yeagle, 1985, 1991). Normal physio-
logical levels of cholesterol in the plasma membrane are essential
to maintain membrane fluidity, thickness, and compartmental-
ization of the lipid domains that constitute scaffolds for multiple
signaling platforms. An increase in membrane cholesterol, how-
ever, may underlie cellular and tissue dysfunction and could
contribute to the pathological effects of hypercholesterolemia. It
is essential, therefore, to understand the mechanisms responsi-
ble for cholesterol regulation of membrane proteins. The current
review focuses on discussing the evidence for direct cholesterol
interactions with ion channels.
Numerous studies showed that a variety of ion channels are
sensitive to the level of membrane cholesterol with the most
common effect being suppression of channel activity that may
include decrease in the open probability, unitary conductance,
and/or the number of active channels on themembrane [reviewed
by Martens et al. (2004); Maguy et al. (2006); Levitan (2009);
Levitan et al. (2010)]. This effect was observed in multiple
types of K+ channels, including inwardly-rectifying K+ channels
(Romanenko et al., 2004a), Ca+2-sensitive K+ channels (Crowley
et al., 2003; Bukiya et al., 2011) and voltage-gated K+ channels
(Hajdú et al., 2003; Abi-Char et al., 2007), as well as in voltage-
gated Na+ and Ca+2 channels (Lundbaek et al., 2004), volume-
regulated anion channels (Romanenko et al., 2004b) and vanilloid
transient receptor potential channels (TrpV) (Picazo-Juarez et al.,
2011). However, cholesterol may also be required for the func-
tional activity of the channels, as it was shown for nicotinic
acetylcholine receptor (nAChR) [reviewed by (Barrantes, 2004,
2007) and GABAA receptors (Sooksawate and Simmonds, 2001)].
Epithelial Na+ channels (eNaC) and several sub-types transient
receptor potential (Trp) channels were also shown to be inhib-
ited by the removal of membrane cholesterol [reviewed by Levitan
et al. (2010)]. Surprisingly, our recent studies showed that choles-
terol may have opposite effects on channel function even within
one sub-family of channels (Rosenhouse-Dantsker et al., 2010). In
terms of the mechanism, one possibility is that cholesterol inter-
acts directly with a channel protein and regulates its function
as a specific ligand. An alternative possibility is that cholesterol
may regulate the channels by altering the physical properties of
the lipid bilayer which in turn affects protein function. More
specifically, it was proposed that cholesterol may regulate ion
channels by an increase in bilayer stiffness and hydrophobic
mismatch between the transmembrane domains and the lipid
bilayer (Lundbaek et al., 1996; Lundbaek and Andersen, 1999).
Discrimination between these possibilities is the major challenge
in elucidating the mechanisms of cholesterol regulation of any
specific type of an ion channel.
Direct interaction between steroids and ion channels was first
demonstrated for the nAChR based on the analysis of lipid mobil-
ity in the vicinity of the protein (Marsh and Barrantes, 1978).
It is important to note, however, that evidence for direct inter-
action does not necessarily discriminate between the two types
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of mechanisms described above because cholesterol may still act
both, as a ligand or as a modifier of the membrane bilayer in
the close vicinity of the channel altering the hydrophobic inter-
action between the channel and the lipids. This question was
further addressed in several studies by altering the sterol com-
position of the membrane substituting native cholesterol with an
array of sterols that have similar effects on the physical proper-
ties of the membrane (Popot et al., 1978; Romanenko et al., 2002,
2004b; Addona et al., 2003; Singh et al., 2009; Bukiya et al., 2011
#2464). Furthermore, direct binding between cholesterol and an
ion channel has been demonstrated for nAChR using a photoac-
tivatable cholesterol probe (Corbin et al., 1998; Hamouda et al.,
2006a) and for a bacterial K+ channel using native cholesterol
(Singh et al., 2011). Most recently, several studies provided the
first insights into the structural determinants of cholesterol-ion
channel interactions identifying several structural motifs that are
proposed to be responsible for cholesterol binding (Picazo-Juarez
et al., 2011; Singh et al., 2012; Rosenhouse-Dantsker et al., 2013).
DIRECT ASSOCIATION OF STEROLS WITH NICOTINIC
ACETYLCHOLINE RECEPTOR: BIOPHYSICAL STUDIES
LIPID BELT OF IMMOBILIZED LIPIDS
Early studies of two groups, Barrantes and colleagues and
Changeux and colleagues, were first to propose direct interaction
of cholesterol with an ion channel based on different experi-
mental approaches. Barrantes and colleagues identified a unique
population of lipids that are associated with nAChR and are
immobilized at the protein-lipid membrane interface (Marsh
and Barrantes, 1978). Specifically, lipid-protein interactions of
nAChR were analyzed using electron spin resonance (ESR) spec-
tra of several lipid probes to reveal a population of lipids that
are immobilized with respect to the protein and distinct from
the general fluid lipid bilayer (Marsh and Barrantes, 1978). This
conclusion was based on the detection of two-component ESR
spectra for both types of probes with the less mobile component
being observed only in the presence of the acetylcholine receptor
protein. This effect, however, is not specific for a particular type
of lipid and is observed for several lipid species including fatty
acids (stearic acid), steroids (androstane), as well as phosphatidyl-
choline, phosphatidylethanolamine, phosphatic acid, and phos-
phatidylserine (Marsh and Barrantes, 1978; Marsh et al., 1981;
Ellena et al., 1983). Changeux and colleagues used a different
approach: they measured the surface pressure of the membrane
after injecting the protein into lipid monolayer films prepared
from different lipids (Popot et al., 1978). Using both approaches,
it was shown that nAChR associates preferably with sterols than
with other lipids (Popot et al., 1978; Ellena et al., 1983). In terms
of the functional effect of cholesterol on nAChR, multiple studies
have shown that incorporation of cholesterol into the phos-
pholipid mixture enhances the functional activity of nAChR in
reconstituted lipid vesicles and that nAChR-mediated ion fluxes
increase proportionally to the amount of cholesterol in the mem-
brane (up to ∼50%) (Dalziel et al., 1980; Criado et al., 1982;
Barrantes, 2004, 2007). It was further demonstrated that while the
requirement for cholesterol is not absolute, increasing cholesterol
level in the membrane stabilizes nAChR channels in the resting
state that undergoes agonist-induced activation whereas at low
cholesterol level the channels become desensitized (daCosta et al.,
2002; Hamouda et al., 2006b). Overall though, these studies show
that nAChR receptor interaction with the surrounding lipids is
a general phenomenon of lipid-protein interaction and whereas
sterols clearly can associate with a channel protein, the specificity
of these effects remained unclear. Significant effort, therefore, has
been dedicated since late 1970s and until today to elucidate the
nature of cholesterol interactions with nAChR.
ANNULAR AND NON-ANNULAR CHOLESTEROL BINDING SITES
Two classes of lipid binding sites have been described: annular
or boundary sites located on the transmembrane surface of a
transmembrane protein, and non-annular sites located between
transmembrane α-helices and occluded to phospholipids. ESR
studies provided the first mechanistic insights into how choles-
terol may interact with the channel proteins. First, it was revealed
that the amount of lipids associated with the nAChR protein
is significantly higher than would be required to form a sin-
gle boundary shell around the protein. It was proposed that
the immobilized lipids fill the space between the transmem-
brane helices of the protein and that this lipid layer may provide
the medium of interaction between the subunits of the recep-
tor (Marsh and Barrantes, 1978). This observation suggests that
cholesterol may interact with the membrane proteins directly
not only on the protein-bilayer interface but between the trans-
membrane subunits of the protein. Furthermore, analysis of
the competition between cholesterol and phospholipids for the
interaction with nAChR on the protein-bilayer interface using
fluorescence quenching showed that cholesterol does not dis-
place phospholipids from nAChR (Jones and McNamee, 1988).
To account for this apparent discrepancy between the prefer-
ential association of nAChR with sterols demonstrated earlier
and the inability of the sterols to displace phospholipids from
the nAChR-lipid bilayer interface, Jones and McNamee (1988)
proposed that cholesterol interacts with nAChR protein at “non-
annular” binding sites that are not accessible to phospholipids.
Clearly, this idea is fully consistent with the ESR analysis byMarsh
and Barrantes (1978) showing that immobilized sterols may fill
the space between the transmembrane helices.
Analysis of sterol ESR spectra in membranes containing
digested segments of the protein provided further insights
into the sterol-protein interactions of nAChR (Dreger et al.,
1997). This study showed that enzymatic digestion of the extra-
membrane domains of nAChR resulted in a significant decrease
in the fraction of motionally restricted sterols consistent with the
loss of sterol binding sites. In contrast, the fraction of the immo-
bilized phospholipids was not affected by the digestion, providing
additional evidence that cholesterol and phospholipids interact
with nAChR through distinct binding sites. The requirement for
the extra-membrane domains of the channel to support its inter-
action with cholesterol was interpreted as additional evidence
for non-annular cholesterol binding sites (Dreger et al., 1997). A
conclusion that cholesterol interacts with nAChR through non-
annular sites was questioned, however, in view of the study of
Addona et al. (1998) showing that tethering cholesterol molecule
to the glycerol backbone of phosphatidylcholine does not prevent
the functional impact of cholesterol on nAChR opening. Indeed,
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it is difficult to reconcile this observation with the idea of intersti-
tial non-annular binding sites located within the channel protein.
Addona et al. suggested, therefore, that functionally important
cholesterol binding sites of nAChR must be close to the protein-
lipid bilayer interface in what they called “peri-annular” locations.
It is also possible, however, that the presence of cholesterol teth-
ered to the glycerol backbone might alter the conformation of
the protein resulting in a shift of the non-annular sites to a more
peri-annular position.
Further evidence for direct interaction between cholesterol
and nAChR came from studies using a photoactivatable choles-
terol analog that cross-links with proteins upon UV illumination
(Corbin et al., 1998; Hamouda et al., 2006a). These studies
showed that the radio labeled photoactivatable cholesterol ana-
log [125I]azido-cholesterol was incorporated into each of the
nAChR subunits at equal molar ratios and that the amount of
[125I]azido-cholesterol binding was found to be proportional to
the surface of the protein-lipid interface leading the authors to
conclude that cholesterol binds nAChR on the interface with the
membrane lipids rather than at non-annular sites (Corbin et al.,
1998). Further studies from the same group demonstrated that
[125I]azido-cholesterol interacts with all transmembrane subunits
(M1, M3, and M4) that contribute to the nAChR lipid protein
interface, again emphasizing the correlation between cholesterol
binding and the lipid-protein interface of nAChR and support-
ing the previous conclusion of the authors that cholesterol binds
to annular rather than non-annular sites of nAChR (Hamouda
et al., 2006a). A major constraint of these studies, however, was
that, as pointed out by the authors, [125I]azido-cholesterol was
added nAChR-containing membranes that already had a signifi-
cant level of cholesterol. Therefore, if the non-annular cholesterol
binding sites were already occupied by native cholesterol that
was stably bound to these sites, they would have been inac-
cessible to the photoactivatable analog. Therefore, while these
studies provide further evidence for direct interaction between
cholesterol and nAChR, the discrimination between annular and
non-annular sites was inconclusive. It was also pointed out in a
later study (Brannigan et al., 2008) that incubation times used in
these studies could be too short to allow labeled cholesterol to
bind to internal non-annular sites. Furthermore, using molecular
dynamics simulations, Brannigan et al. (2008) identified puta-
tive cholesterol-binding sites both at the protein-lipid interface
of nAChR and sites that are deeply buried between the trans-
membrane subunits of the channels. Both sites were proposed to
contribute to cholesterol functional effects on the nAChR chan-
nels. It is important to note, however, that the fact that cholesterol
interacts directly with the protein does not necessarily mean that
specific binding is required. Direct interaction of cholesterol with
the channel protein might also alter channel function by the
hydrophobic mismatch and increase in membrane deformation
energy mechanisms.
SPECIFIC vs. NON-SPECIFIC CHOLESTEROL-ION CHANNELS
INTERACTIONS: COMPARATIVE STEROL ANALYSIS
A powerful tool to discriminate between specific and non-specific
effects of cholesterol on protein function is the substitution of
endogenous cholesterol with sterols that have similar effects on
the physical properties of the membrane. The rationale of this
approach is that if cholesterol analogs have the same effects on
the membrane structure and physical properties of the bilayer
but differential effect on an ion channel function, it provides
evidence for the specificity of the cholesterol effect. To achieve
this goal, multiple studies used the substitution of cholesterol
by one of its chiral analogs (enantiomers), a method based on
the assumption that cholesterol enantiomers should have iden-
tical effects on the physical properties of the membrane but be
strongly distinct in their ability to interact with the proteins. It is
important to note, however, that while enantiomers have identi-
cal physical properties in an achiral environment, their effects on
the physical properties of the lipid membranes depend on their
interaction with other lipids and may not be identical because
of the enantioselectivity of cholesterol-phsopholipid interactions
[see Westover and Covey (2004) for review]. In spite of these con-
straints, two synthetic cholesterol analogs have been widely used
to study the specificity of cholesterol-protein interactions: epi-
cholesterol (3α-hydroxy-5-cholestene) that differs from natural
cholesterol (3β-hydroxy-5-cholestene) in the rotational angle of
the hydroxyl group at position 3 and ent-cholesterol that differs
from natural cholesterol in the configuration of each of the eight
stereocenters.
The rationale for using epicholesterol to substitute natural
cholesterol in order to discriminate between specific and non-
specific effects in cholesterol is based on the studies that showed
that cholesterol and epicholesterol have similar effects on mem-
brane fluidity (Gimpl et al., 1997) and on the formation of
structured lipid domains (Xu and London, 2000). However, while
cholesterol has a significant condensing effect on the areas of
other lipids, epicholesterol has a weaker or no effect (Demel et al.,
1972a,b). Cholesterol and epicholesterol also have different ori-
entation (tilt angle) within the lipid bilayer and while cholesterol
is tilted in parallel to the phospholipids, epicholesterol resides
more perpendicular to the surface of the bilayer (Murari et al.,
1986). These studies suggest that the two sterols might have dif-
ferential effects on the lipid packing of the membrane. In many
studies, therefore, as described below, cholesterol was substituted
not only by epicholesterol but by an array of different sterols to
determine the correlation between the impact of the sterols on
the physical properties of the membrane and on the activity of a
specific protein. Clearly, the benefit of the latter approach is that it
allows to directly test for correlation between the two effects in a
given system.More recently, there is growing interest in using ent-
cholesterol that appears to be the closest to natural cholesterol in
terms of its impact on the physical properties of the lipid bilayer
including membrane thickness, a parameter that might be more
critical for protein function than membrane fluidity and com-
pression behavior (Mickus et al., 1992; Rychnovski and Mickus,
1992;Westover and Covey, 2004). Here, we describe how different
sterol substitutions have been used to determine the specificity of
cholesterol interactions with various ion channels. All the effects
are summarized in Table 1.
NICOTINIC ACETYLCHOLINE RECEPTOR (nAChR)
An early study of Popot et al. (1978) used this approach to ana-
lyze the ability of nAChR to be incorporated into monolayer lipid
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Table 1 | Sterol specificity of cholesterol effects on different types of ion channels.
Channel Assay Substitutions Conclusion




nAChR Incorporation into films No selectivity – No correlation Specific (Popot et al., 1978)
Agonist-induced activity No selectivity No selectivity No correlation Specific (Addona et al., 2003)
GABAA Agonist-induced activity Partial specificity – – Specific (Sooksawate and Simmonds, 2001)
VRAC Swelling-induced activity No selectivity – Correlation Nonspecific (Romanenko et al., 2004b)
Kir channels
Kir2.1 Whole-cell current Stereospecificity – – Specific (Romanenko et al., 2002)
Activity in liposomes – Stereospecificity – Specific (D’Avanzo et al., 2010)
KirBac1.1 Activity in liposomes Stereospecificity – No correlation Specific (Singh et al., 2009)
Binding No selectivity – – Specific (Singh et al., 2011)
BK channels Activity in bilayers Stereospecificity Stereospecificity No correlation Specific (Bukiya et al., 2011)
TRPV1 Capsaicin-induced current Stereospecificity – – Specific (Picazo-Juarez et al., 2011)
films that contained different sterol analogs, including choles-
terol, ergosterol, epicholesterol, androstenol, stigmasterol, and
coprostenol. Using this approach, Popot et al. showed that the
ability of nAChR to be incorporated into the monolayers con-
taining cholesterol was significantly higher than that for mono-
layers containing ergosterol while both sterols were shown earlier
to have the same effects on membrane permeability to small
molecules (Demel et al., 1972a). This observation was interpreted
as evidence for direct interaction of cholesterol with nAChR
(Popot et al., 1978). No significant difference, however, was
observed between nAChR incorporation into monolayers con-
taining cholesterol and epicholesterol. This early study suggested,
therefore, that both cholesterol and epicholesterol may interact
with the nAChR protein.
These findings were confirmed by a more recent study of
Addona et al. (2003) who showed that similarly to cholesterol,
epicholesterol can support the functional activity of nAChR.
Furthermore, the same results were observed when choles-
terol was substituted with ent-cholesterol. Based on the original
premise of this approach, these observations could have been
interpreted as evidence that nAChR is regulated by the physical
properties of the membrane rather than by direct interactions
between the sterols and the protein. However, Addona et al. also
found that nAChR functional activity can also be supported by
coprastanol, a sterol that lacks the planar structure that is crit-
ical for the typical effects of cholesterol on lipid bilayer. Taken
together with the earlier studies that showed immobilization of
cholesterol molecules by nAChR protein described above, the
conclusion was that cholesterol binds directly to the nAChR but
that the binding site has very lax structural requirements and the
binding is not stereo-selective (Addona et al., 2003). Interestingly,
new mechanistic insights into the role of cholesterol in the reg-
ulation of nAChR were obtained by a recent study of daCosta
et al. (2013) showing that cholesterol regulates the channels by
two distinct mechanisms: stabilization of the channels in a rest-
ing state that depends on specific lipid-protein interactions and
facilitation of the transitions between uncoupled and coupled
states that depends on the hydrophobic thickness of the mem-
brane. A detailed analysis of cholesterol binding motifs that
are responsible for cholesterol interaction with the nAChR is
provided in later sections of this review.
GABAA RECEPTOR
Similarly to nAChR, cholesterol was shown to be required
to support agonist-induced opening of the GABAA receptor
(Sooksawate and Simmonds, 2001), a member of a superfamily
of ligand-gated ion channels that forms a chloride channel. In
this case, however, the effect was stereospecific because repletion
of cholesterol-depleted cells with epicholesterol failed to sup-
port GABAAfunction. In addition, the authors showed that not
only cholesterol depletion but also cholesterol enrichment has
a detrimental effect on GABAAfunction but the latter appeared
to be non-specific. The authors concluded that GABAA recep-
tor is regulated by cholesterol by both specific and non-specific
mechanisms. It was also suggested that since nAChR and GABAA
belong to a superfamily of Cys-loop receptors, the same mech-
anisms may apply to cholesterol regulation of the two proteins
(Brannigan et al., 2008). Clearly, more studies are needed to test
this prediction.
VOLUME-REGULATED ANION CHANNELS (VRAC)
In contrast to nAChR and GABAA receptors, VRAC channels
were shown to be suppressed by an increase in membrane choles-
terol and enhanced by cholesterol depletion (Levitan et al., 2000;
Klausen et al., 2006). The channels are activated in response to an
osmotic gradient that causes cell swelling and the effect of choles-
terol depends on the intensity of the stimulus: when cells are
challenged with amild osmotic gradient, cholesterol strongly sup-
presses the currents but when cells are exposed to a high gradient,
no more inhibition is observed, suggesting that strong stimulus
overcomes cholesterol-induced inhibition (Levitan et al., 2000).
Furthermore, we showed that substitution of cholesterol with
Frontiers in Physiology | Membrane Physiology and Membrane Biophysics February 2014 | Volume 5 | Article 65 | 4
Levitan et al. Cholesterol as a ligand of ion channels
epicholesterol has no impact on VRAC activity indicating that
cholesterol effect on VRAC is not stereoselective (Romanenko
et al., 2004b). Substituting cholesterol with coprastanol, however,
had a significant effect which is consistent with the sensitivity of
the channels to lipid packing.
INWARDLY-RECTIFYING K+ CHANNELS (Kir)
Our studies also showed that Kir channels are strongly suppressed
by an increase in membrane cholesterol and enhanced by
cholesterol depletion (Romanenko et al., 2002, 2004a). This effect
was observed in aortic endothelial cells in vitro and in vivo
(Romanenko et al., 2002; Fang et al., 2006; Mohler et al., 2007),
cardiomyocytes (Deng et al., 2012), macrophages (not pub-
lished) and in several expression systems (Romanenko et al.,
2004a; Rosenhouse-Dantsker et al., 2010). Unexpectedly, sub-
stituting ∼50% of endogenous cholesterol with epicholesterol
resulted in a significant increase in endothelial Kir currents
beyond the effect of cholesterol depletion (Figure 1; Romanenko
et al., 2002). The reason that it was a surprising finding is that
it did not fit neither with the scenario that cholesterol regulates
the channels by altering the physical properties of the mem-
brane, nor with the scenario that it binds to the channel protein
in a stereo-selective way. Indeed, if cholesterol regulates Kir by
altering the physical properties of the membrane than substitut-
ing it with a sterol that has similar properties should have no
effect. On the other hand, if cholesterol regulates Kir channels
by stereo-specific binding, then epicholesterol is expected to be
“invisible” for the channels and cholesterol-epicholesterol sub-
stitution should have a “depletion” effect. Instead, we proposed
that, similarly to nAChR, cholesterol regulates Kir channels by
direct interaction with the channel protein and that this inter-
action is not stereospecific. However, in contrast to nAChR, we
proposed that while the binding of the sterols to Kir channels is
not stereospecific, the functional effect of the binding is. That
means that while epicholesterol might be able to bind to Kir
channels, it does not have an inhibitory effect. Furthermore, in
this case, cholesterol and epicholesterol might compete for the
same binding sites which would explain epicholesterol-induced
increase in Kir activity.
Sensitivity of the channels to the chiral structure of cholesterol
in the complex environment of the plasma membrane, however,
may not necessarily mean that cholesterol interacts directly with
the channels. Obviously, cholesterol may affect channels function
by interacting with other proteins, which in turn may regulate the
activity of the channels. To address this issue, we tested cholesterol
sensitivity of purified bacterial K+ channels, KirBac1.1 incor-
porated into liposomes that have no other protein components
(Singh et al., 2009). KirBac channels have been used in multiple
studies as structural models of mammalian Kir channels because
of their high sequence homology to mammalian Kirs (e.g., 52%
homology between KirBac1.1 and Kir2.1) (e.g., Bichet et al., 2003;
Kuo et al., 2003). Our study showed that no intermediates are
required for the effect of cholesterol on KirBac1.1 channels (Singh
et al., 2009). Furthermore, structural analysis of KirBac1.1 sen-
sitivity to multiple sterols showed that there is no correlation
between the effects of the sterols on KirBac1.1 and on membrane
fluidity indicating that membrane fluidity cannot account for the
effects of the sterols on KirBac1.1 activity (Figure 2; Singh et al.,
2009). Consistent with these observations, D’Avanzo et al. (2011)
showed that cholesterol also suppresses the function of purified
mammalian Kir2.1 channels and that this effect is lost when
cholesterol is substituted with ent-cholesterol. Importantly, the
latter observation indicates that ent-cholesterol does not support
the functional effect of cholesterol on Kir channel but it is fully
compatible with the idea that sterol analogs of cholesterol may
bind to the channel protein but fail to exert a functional effect.
Our further studies demonstrated that cholesterol indeed binds to
purified KirBac1.1 channels (Singh et al., 2011) and most recently
we provided a first comprehensive analysis of putative cholesterol
binding sites of Kir2.1 channels (Rosenhouse-Dantsker et al.,
FIGURE 1 | Substitution of cholesterol by epicholesterol increases
Kir current density. (A) Substitution of endogenous cholesterol by
epicholesterol using MβCD. Dark bars represent the level of
cholesterol, and the lighter portion of the bar, epicholesterol level. (B)
Typical current traces recorded from a cell exposed to
MβCD-epicholesterol and from a control cell. Both cells were
maintained in 6mM extracellular K+. (C) Peak current densities of
MβCD-epicholesterol treated cells (n = 32) and in control cells (n = 31)
recorded in 6mM extracellular K+. All values are means ± SE
∗P < 0.05 vs. control. From Romanenko et al. (2002).
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FIGURE 2 | Differential effects of sterol on KirBac1.1-mediated 86Rb+
uptake. (A) Time-courses of 86Rb+uptake in liposomes containing different
sterols. All experiments included control liposomes containing no sterol
and liposomes containing 50μg cholesterol/mg PL as a positive control.
(B) KirBac1.1 activity vs. membrane anisotropy. The normalized maximal
uptake of 86Rb+ isplotted vs. the anisotropy (r) following incorporation of
respective sterols. The correlation coefficient between the 86Rb+ uptake
and the anisotropy value is R = −0.08276, p > 0.05 (a meaningful
correlation would require |R|> 0.602) (Abbreviations: 25-HC,
25-Hydroxycholesterol; Desm, Desmosterol; β-Sito, β-Sitosterol; Camp,
Campesterol; Fuco, Fucosterol; Chol, Cholesterol; Copro, Coprosterol;
19-HC, 19-Hydroxycholesterol; Epicopro, Epicoprosterol; Epichol,
Epicholesterol; Andro, 5-Androsten 3β-17 β-diol; Ergo, Ergosterol; Stigma,
Stigmastanol). From Singh et al. (2009).
2013). These studies are described in later sections of this
review.
LARGE-CONDUCTANCE Ca2+-SENSITIVE VOLTAGE-GATED K+
CHANNELS (BK)
Several studies demonstrated that elevation of membrane choles-
terol inhibits BK activity both in native cell membranes (Bolotina
et al., 1989) and in reconstituted bilayers (Crowley et al.,
2003; Bukiya et al., 2008, 2011). Initially, it was proposed
that cholesterol-induced inhibition of BK channels should be
attributed to a decrease in membrane fluidity (Bolotina et al.,
1989) or increase in bilayer lateral stress (Chang et al., 1995).
More recent studies of Dopico and colleagues, however, demon-
strated that this is not the case. Specifically, Bukiya et al.
(2011) showed that substituting cholesterol with epicholesterol
resulted in a complete loss of sterol-induced inhibition of BK
channel activity. Furthermore, substitution of cholesterol with
ent-cholesterol had the same effect: in contrast to cholesterol,
incorporation of either epicholesterol or ent-cholesterol into the
bilayer had no effect on the activity of BK channels. Remarkably,
substitution of cholesterol with coprastanol or with cholestanol
had the same effect on BK function as cholesterol. This observa-
tion is very significant because, as described above, coprastanol
lacks the planar structure that is important for the condensa-
tion effect of the sterol on lipid packing. Indeed, coprastanol
was shown to disrupt lipid packing and have “anti-condensation
effect” (Xu and London, 2000; Bukiya et al., 2011). Thus, the abil-
ity of coprastanol to have the same effect on channel function as
that of cholesterol indicates that this effect cannot be attributed
to changes in lipid packing. Interestingly, the ability of copras-
tanol to inhibit BK channels is abolished when it is substituted
with epicoprastanol showing that this effect is also stereospe-
cific. Taken together, these observations led to the conclusion
that cholesterol regulates BK channels by specific sterol-protein
interactions and not by changing the physical properties of the
membrane. Furthermore, similarly to the studies described above
for nAChR and Kir channels, the structural requirements for
cholesterol interaction with the BK channels are expected to
be lax.
TRANSIENT RECEPTOR POTENTIAL VANILLOID 1 CHANNELS (TRPV1)
Cholesterol was also shown to have a significant impact of dif-
ferent types of Transient Receptor Potential (TRP) channels,
including TRPV1. Earlier studies demonstrated that cholesterol
depletion results in strong suppression of the capsaicin-induced
whole cell currents and it was suggested that TRPV1 channels
need a cholesterol-rich environment of a lipid raft for their func-
tion (Liu et al., 2006; Szoke et al., 2010). This conclusion though
was challenged in a later study by Rosenbaum and colleagues
(Picazo-Juarez et al., 2011) who used excised patches to test the
effect of cholesterol on TRPV1 channels. This study showed that
cholesterol had no effect on TRPV1 channels and that choles-
terol enrichment had a strong inhibitory effect. The discrepancy
between this and earlier studies was explained by a possible effect
of cholesterol on TRPV1 trafficking to themembrane which could
have masked the effect of cholesterol on the individual channels.
In terms of the specificity of cholesterol-induced inhibition of
TRPV1 channels, Picazo-Juarez et al. showed that substitution
of cholesterol by epicholesterol abrogated the inhibitory effect
indicating that this effect is stereoselective.
In summary, most types of ion channels analyzed today for
the specificity of their interaction with cholesterol appear to be
regulated by specific sterol-protein interactions. It is important to
note, however, that the specificity may not manifest itself in the
stereoselectivity of the responses, as it was shown for the nicotinic
AChR (Addona et al., 2003). Multiple criteria, therefore, should
be used to determine whether this is the case. Furthermore, given
a possible lack of stereospecificity of cholesterol interaction with
ion channels, it is imperative to develop further assay that test
cholesterol-ion channel binding directly.
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DIRECT BINDING OF CHOLESTEROL TO ION CHANNELS
EVIDENCE FOR DIRECT BINDING OF CHOLESTEROL TO KirBac
CHANNELS
Direct evidence for cholesterol binding has been demonstrated
so far only for a small number of proteins (Gimpl, 2010).
Traditionally, binding studies are performed by incubating a pro-
tein with a radiolabeled ligand and then separating the bound
and free ligand by different centrifugation or filtration techniques.
This approach, however, is significantly more challenging for
water insoluble ligands, such as cholesterol, because organic sol-
vents might interfere with specific sterol-protein interactions of
membrane proteins (Radhakrishnan et al., 2004; Gimpl, 2010).
Thus, the main constraint in establishing a cholesterol binding
assay is solubilizing cholesterol without disrupting the binding
ability of the protein. Earlier studies have shown that this prob-
lem can be successfully resolved by solubilizing cholesterol in
detergent micelles of either Fos-Choline 13 or Nonidet P-40 and
using His-tagged proteins that can be separated on nickel agarose
columns (Radhakrishnan et al., 2004; Infante et al., 2008a,b).
Using this approach, saturation and kinetic data for cholesterol
binding was obtained for two major cholesterol binding pro-
teins, SCAP1 and NPC1 (Radhakrishnan et al., 2004; Infante
et al., 2008a,b). We used the same approach, therefore, to ana-
lyze cholesterol binding to purified KirBac channels. In this case,
we used another detergent, 3-[(3-Cholamidopropyl) dimethyl-
ammonio]-propanesulfonate hydrate (CHAPS) for cholesterol
solubilization, which we have already shown earlier not to inter-
fere with KirBac1.1 function and its sensitivity to cholesterol
(Singh et al., 2009). Indeed, we have found that cholesterol binds
to KirBac1.1 protein in a reproducible way, as is demonstrated by
a typical [3H]cholesterol elution profile (Figure 3A). As expected,
the profile consists of two clear peaks that correspond to the
unbound (fractions 1–4) and bound cholesterol (fractions 5–7).
SATURABILITY
We also found that the binding is clearly saturable but the satura-
tion occurred at relatively high cholesterol concentration with the
KD estimated to be ∼400μM (Singh et al., 2011). This is signif-
icantly higher than the KD values estimated for SCAP and NPC
proteins that range between 30 nM and ∼2μM (Gimpl, 2010). It
is important to note, however, that the environment of the plasma
membrane where Kir channels are functional is also significantly
richer in cholesterol than the intracellular membranes that har-
bor SCAP and NPC proteins. It would make sense, therefore, for
Kir channels to have lower affinity to cholesterol than the intra-
cellular proteins. It is important to note, however, that KirBac is
a bacterial protein that is not exposed to cholesterol in its natu-
ral environment. The fact that KirBac still binds cholesterol and
is functionally regulated by changes in cholesterol levels provides
further support for the structural-functional homology between
bacterial and mammalian Kir channels. Moreover, the high KD
value suggests that most likely cholesterol interacts with the chan-
nel protein by weak hydrophobic association. It is also interesting
to note that bacterial channels are not exposed to cholesterol in
nature. In terms of the functional significance, therefore, one pos-
sibility is that the channels may interact with other sterols that
are present in bacteria but this has not been studied. Another
FIGURE 3 | Specific cholesterol binding to KirBac1.1. (A) Typical elution
profiles of [3H]-cholesterol with and without 1.5μg His6-KirBac1.1 protein
from Ni-NTA-agarose affinity column. The unbound cholesterol is eluted in
fractions 1–4 and cholesterol bound to the KirBac1.1 protein is eluted in
fractions 5–7 after the addition of imidazole-HCl. (B) Competition between
3H-cholesterol and unlabeled cholesterol, epicholesterol,
25-Hydroxycholesterol and, 5-Androsten 3β-17 β-diol. From Singh et al.
(2011). ∗p < 0.05.
possibility is that the general structure of multiple membrane
proteins including bacterial ion channels has hydrophobic sur-
faces in between their transmembrane helices that are capable
to bind cholesterol molecule. In the presence of cholesterol, such
surfaces may develop into regulatory sites.
COMPETITION WITH OTHER STEROLS: NO DIFFERENCE BETWEEN
CHOLESTEROL AND EPICHOLESTEROL
To examine the specificity of sterol binding to KirBac channels,
we tested three sterols: epicholesterol, 5-Androsten 3β-17β-diol
and 25-hydroxycholesterol. Our previous studies showed that
epicholesterol is significantly less efficient than cholesterol in sup-
pressing KirBac activity and androsten and 25-hydroxycholesterol
do not affect the channels at all (Singh et al., 2009). These exper-
iments showed that while epicholesterol binding to KirBac1.1
was similar to that of cholesterol, 25-hydroxycholesterol bind-
ing was significantly weaker and 5-Androsten 3β-17β-diol did
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not compete with cholesterol at all (Figure 3B). Thus, cholesterol
binding to the KirBac protein is clearly specific. The most sig-
nificant and novel result of this series of experiments was that
epicholesterol was found to bind to the channel protein as effi-
ciently as cholesterol. The novelty of this observations is not in
the fact that epicholesterol was found to interact with a protein.
Indeed, as described above, both chiral analogs of cholesterol,
epicholesterol, and ent-cholesterol were found to interact with
nAChR (Addona et al., 2003). Epicholesterol was also found to
bind to a sterol-sensing domain of SCAP (Radhakrishnan et al.,
2004). Themajor difference, however, is that in nAChR epicholes-
terol is also capable of substituting for cholesterol in terms of its
functional effect on the channel whereas in Kir channels, this is
not the case.
In summary, these studies provide proof of principle that spe-
cific saturable binding of cholesterol to an ion channel can be
detected using the appropriate biochemical techniques and con-
firm that Kir channels can be regulated by specific sterol-protein
interactions. These studies also provide novel insights into the
differential effects of sterols on channel function by raising an
important question about the interpretation of comparative anal-
ysis of sterol analogs on ion channel function. In contrast to
a common interpretation that differential effects of cholesterol
enantiomers on channel function indicate a lack of analog bind-
ing, our observations suggest that chiral analogs may bind to the
channel protein but have no inhibitory effect. The latter inter-
pretation is also supported by our earlier studies showing that
cholesterol and epicholesterol have opposite effects on Kir cur-
rents suggesting that the two analogs compete for a binding site
(Romanenko et al., 2002).
STRUCTURAL FEATURES OF CHOLESTEROL INTERACTION
WITH ION CHANNELS
As described above, earlier studies provided evidence for non-
annular cholesterol binding regions in nAChR (Jones and
McNamee, 1988) as described earlier in this review, and in Ca2+-
ATPase of sarcoplasmic reticulum (Simmonds et al., 1982). More
recently, X-ray crystallography revealed cholesterol molecules
bound between the transmembrane helices of several G-protein
coupled receptors (GPCRs) (Yeagle, 2013). For example, several
cholesterol molecules were found between four transmembrane
helices (I, II, III, and IV) of the β-Adrenergic GPCR (Cherezov
et al., 2007; Hanson et al., 2008) as well as a cholesterol molecule
wedged within a groove formed by three transmembrane helices
(Ia, V, and VII) of the dopamine receptor (Penmatsa et al.,
2013). A cholesterol binding site was also identified in the 5-
HT2BERG receptor (Wacker et al., 2013) and three cholesterol
binding sites were found in the crystal structure of human A2A
adenosine receptor (Liu et al., 2012). Additional examples include
also two cholesterol molecules that were observed in the proton
pumping Rhodopsin, ARII, between the transmembrane helices
of two adjacent proteins (I and VII in one protein and I in
the adjacent protein) (Wada et al., 2011), and one cholesterol
molecule that was seen in the structure of the μ-opiod receptor
in between the transmembrane helices of two receptors (Manglik
et al., 2012). Most recently, our studies identified two puta-
tive non-annular cholesterol binding regions in Kir2.1 channels
(Rosenhouse-Dantsker et al., 2013). The goal of this part of the
study is to describe the structural features of cholesterol binding
motifs and putative binding regions in ion channels.
CHOLESTEROL BINDING MOTIFS: CRAC, CARC, AND CCM
Three motifs have been previously associated with cholesterol
binding to transmembrane proteins. The most well-known motif
is the cholesterol recognition amino acid consensus (CRAC)
motif, which is -L/V-(X)(1–5)-Y-(X)(1–5)-R/K- where (X)(1–
5) represents between one and five residues of any amino acid
(Li and Papadopoulos, 1998; Epand, 2006). Accordingly, choles-
terol binding requires a bulky hydrophobic residue (leucine or
valine), the aromatic residue tyrosine, and a positively charged
residue (arginine or lysine). Recently, an inverted CRAC motif,
the CARC motif, has been shown to be more consistent in
predicting cholesterol recognition motifs in integral membrane
proteins (Fantini and Barrantes, 2013). As its name hints, the
order of the required residues for cholesterol binding is inverted
in the CARC motif compared with their order in the CRAC
motif. Additionally, in this motif the tyrosine can be replaced
by a different aromatic residue, a phenylalanine. In summary,
the CARC motif is R/K-(X)(1–5)-Y/F-(X)(1–5)-L/V. The third
established cholesterol binding motif is the cholesterol consen-
sus motif (CCM) (Hanson et al., 2008). Unlike the CRAC and
CARCmotifs that include residues from one continuous segment
of the protein, the CCM includes residues on adjacent helices:
(W/Y)-(I/V/L)-(K/R) on one helix, and (F/Y/R) on the second
helix. Notably, the types of residues included in the CCM are
similar to those in the CRAC and CARC motifs. In recent years,
both the CRAC motif and its inverted version, the CARC motif,
have been found in several ion channels. These include the tran-
sient receptor potential TRPV1 channels (Picazo-Juarez et al.,
2011), the large conductance Ca2+ and voltage-gated K+ (BK)
channels (Singh et al., 2012), the nicotinic acetylcholine recep-
tor (nAChR) (Fantini and Barrantes, 2013), and the inwardly
rectifying potassium channel Kir2.1 (Rosenhouse-Dantsker et al.,
2013).
CRAC motifs
CRAC motifs were found in BK, nAChR, and Kir2.1 channels.
In BK, seven CRAC motifs were found in the cytosolic domain
(Singh et al., 2012) with the most pronounced effect on the
sensitivity of the channel to cholesterol found in the membrane-
adjacent CRAC4 motif, V444—Y450—K453. In addition, cumu-
lative truncations or Y-to-F substitutions in CRAC5 to CRAC10
progressively decreased the sensitivity of the channel to choles-
terol, demonstrating the role of multiple CRACs in the sensitivity
of BK channels to cholesterol. A CRAC motif was also found in
AChR subunits in the region immediately adjacent to TM1 and
stretching out into the extracellular domain of the AChR but in
view of its location outside the membrane bilayer, it was sug-
gested that this CRAC motif would not be energetically favorable
for cholesterol binding (Fantini and Barrantes, 2013). Similarly,
a CRAC motif was also found in Kir2.1 outside the transmem-
brane domain, in a cytosolic segment that is highly energetically
unfavorable for cholesterol binding (Rosenhouse-Dantsker et al.,
2013).
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CARC motifs
CARC motifs, on the other hand, were identified in the trans-
membrane domain of TRPV1 (Picazo-Juarez et al., 2011), AChR
(Fantini and Barrantes, 2013), and Kir2.1 (Rosenhouse-Dantsker
et al., 2013) providing more favorable putative cholesterol bind-
ing sites. In TRPV1, the R-(X)(2)-F-(X)(2)-L CARC sequence
R579—F582—L585 is located in the S5 transmembrane helix of
the channel. Mutations of the three characteristic CARC motif
residues affected the sensitivity of TRPV1 to cholesterol (Picazo-
Juarez et al., 2011). In AChR, three cholesterol molecules could
be docked on the TM1, TM3, and TM4 transmembrane helices
of each AChR subunit (Fantini and Barrantes, 2013). All three
sites corresponded to CARC motifs, rendering a total of 15 possi-
ble cholesterol binding sites per AChR molecule. In Kir2.1, there
are several CARC motifs in both the cytosolic and transmem-
brane domain. Aside from the CARC motifs that are located in
the cytosolic domain and are unfavorable for cholesterol binding,
Kir2.1 has two CARC motifs at the interface between the trans-
membrane and cytosolic domains (Rosenhouse-Dantsker et al.,
2013). These include (1) R67—F73—V77 and (2) R82—F88—
L90. In the first CARC motif, the V77I mutation resulted in loss
of cholesterol sensitivity. However, the roles of the other two
residues (R67 and F73) could not be tested because their muta-
tions resulted in non-functional channels. In contrast, mutations
of all three residues of the second CARC motif, did not affect the
sensitivity of the channel to cholesterol suggesting that it does not
describe a cholesterol binding site in these channels. The existence
of a CRAC/CARCmotif does not necessarily imply, however, that
cholesterol would bind to the protein at the corresponding region.
Furthermore, it is also possible that the three cholesterol bind-
ing motifs described above do not account for all the possible
cholesterol-protein interactions, and that cholesterol may inter-
act with ion channels through previously unidentified interaction
motifs.
NOVEL CHOLESTEROL BINDING REGIONS IN Kir2.1
A lack of putative cholesterol binding sites at the annular sites of
the transmembrane domain and in the cytosolic domain of Kir2.1
channels
We have shown earlier that mutations of residues located at the
lipid-protein interface of the transmembrane domain do not
affect cholesterol sensitivity of Kir2.1 suggesting that cholesterol
does not bind to annular sites of Kir2.1 (Epshtein et al., 2009). We
have also identified a series of residues in the cytosolic domain of
Kir channels that significantly reduced or abrogated the sensitiv-
ity of Kir2.1 to cholesterol but based on the docking analysis, our
conclusion was that these residues do not constitute a cholesterol
binding site (Epshtein et al., 2009; Rosenhouse-Dantsker et al.,
2011; Rosenhouse-Dantsker and Levitan, 2012). Specifically, we
first identified several residues in the CD loop of the cytoso-
lic domain of the channel (N216, K219, and L222) (Epshtein
et al., 2009) and then showed that these residues are a part
of a group of residues that form a belt structure surrounding
the cytosolic pore of the channel close to its interface with the
membrane (Rosenhouse-Dantsker et al., 2011). Yet, there was
no correlation between the location of the cholesterol sensitiv-
ity belt and any potential cholesterol binding sites obtained from
docking analysis. Rather, all potential binding sites were located
either above or below the plane of the cholesterol sensitivity belt
(Rosenhouse-Dantsker et al., 2011) Our conclusion was therefore,
that cholesterol sensitivity belt does not constitute a cholesterol
binding site but regulates cholesterol sensitivity of the channels
by affecting channel gating. Thus, no putative cholesterol binding
sites were found neither at the annular sites of the transmembrane
domain nor in the cytosolic domain of Kir2.1 channels.
Identification of novel non-annular cholesterol binding regions in
Kir2.1 channels
To identify possible non-annular cholesterol-binding sites in
Kir2.1, we used a combination of docking studies, all-atom
molecular dynamics simulations and site-directed mutagenesis,
an approach that led to the identification of two novel putative
cholesterol binding regions (Rosenhouse-Dantsker et al., 2013).
One binding region is located in the center of the transmembrane
domain of Kir2.1 (region 1), and the second—at the interface
between the transmembrane and cytosolic domains of the
channel (region 2) (Figures 4, 5). Within region 1 we identified
8 residues whose mutation abrogated or significantly decreased
the sensitivity of the channel to cholesterol (Figures 4A–D).
These residues are primarily bulky hydrophobic (I, L, or V),
but also include a polar uncharged serine residue. Mutations of
several aromatic and positively charged residues located in this
region resulted in a non-functional channel or did not have any
effect on the sensitivity of the channel to cholesterol. Their role
in cholesterol binding, however, cannot be excluded because
mild mutations may not sufficiently affect the interaction of the
channel with the cholesterol molecule. Notably, the 8 residues in
region 1 whose mutation affected the sensitivity of the channel
to cholesterol were distributed among the α-helices of two
adjacent subunits of the channel. Accordingly, the cholesterol
molecule would bind in between these α-helices. Within region
2, we identified 5 hydrophobic residues (A, L, V, and M) whose
mutation abrogated or significantly decreased the sensitivity of
the channel to cholesterol (Figures 4A–C,E). Similarly to the
cholesterol binding pocket in region 1, these 5 residues are located
in two adjacent subunits of the channel indicating that also in
this region, cholesterol would bind in between the α-helices.
Furthermore, based on all-atom full-membrane 50 ns molecular
dynamics simulations, cholesterol molecule exhibited significant
flexibility, continuously exploring a considerable conformational
space within each binding region, and interacting with different
sets of residues in these two regions (Rosenhouse-Dantsker et al.,
2013). It is possible that this flexibility accounts for a lack of
stereospecificity of cholesterol binding to Kir channels that is
described above (Singh et al., 2011).
The predicted positions of the cholesterol molecule within
both putative cholesterol binding regions that we have iden-
tified suggest these regions constitute non-annular cholesterol
binding sites. Molecular dynamics simulations provide further
support to this hypothesis, demonstrating that these regions are
non-annular surfaces that prefer cholesterol to phospholipids
(Rosenhouse-Dantsker et al., 2013). Specifically, our simulations
showed that for every pose in which cholesterol resided stably
for the entire length of the 50 ns molecular dynamics simulation,
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FIGURE 4 | Cholesterol recognition residues in the two putative
transmembrane binding regions in Kir2.1. Whole-cell basal currents
recorded in Xenopus oocytes at −80mV showing the effect of cholesterol
enrichment on Kir2.1 and (A) L69I, A70V, and V77I of the slide helix, (B)
L85I, V93I, and S95T of the outer helix, and (C) I166V, V167L, I175L, and
M183I of the inner helix (n = 9–90). Significant difference is indicated by
an asterisk (∗p ≤ 0.05). A black asterisk indicates significant difference
between whole-cell currents obtained for same construct following
cholesterol enrichment and in the absence of treatment (control). A blue
asterisk indicates significant difference between the effect of cholesterol
enrichment on a mutant and the WT Kir2.1 channel. (D,E) Stick and ball
presentations of the cholesterol recognition residues that surround the
cholesterol molecule in each of the two putative binding regions after
50 ns of all-atom full-membrane molecular dynamics simulations. Two
representative poses in region 1 are shown in (D) and one representative
pose in region 2 is shown in (E). The relative position of each binding
regions in the TM domain of the channel is shown in the ball presentation
that includes the two adjacent subunits of the channel that interact with
the cholesterol molecule in a cartoon presentation. From
Rosenhouse-Dantsker et al. (2013).
the bound cholesterol molecule interacted more favorably than
a single phospholipid targeting the same residues. Our anal-
ysis suggested that this specificity is a result of the matching
between the cholesterol molecule and the hydrophobic and aro-
matic moieties in the two putative cholesterol binding regions. As
a result, phospholipids only transiently interact with the residues
that form the cholesterol binding surface. According to a con-
tact analysis, during the 50 ns molecular dynamics simulations,
there was an average of 35 lipid binding/unbinding events to
the two putative cholesterol-specific binding pockets, further
supporting the notion that these cholesterol binding regions
are non-annular surfaces that are occluded from phospholipid
binding.
The strength of the interactions between the cholesterol
molecule and each of the two putative cholesterol binding regions
can be assessed by calculating the binding enthalpy, a quantita-
tive indicator of changes in the binding energy that depends on
two key factors, van-der-Waals interactions between cholesterol
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FIGURE 5 | Location of the putative transmembrane cholesterol
binding regions in Kir2.1. (A) Ribbon presentation of two adjacent
subunits of Kir2.1 (pink and gray) showing the TM residues whose
mutation affects the sensitivity of the channel to cholesterol (in red balls)
relative to the location of the five cholesterol sites (in cyan sticks and
surface presentation). Also shown are the continuous chains of residues
that border the cholesterol binding groove in the channel (in blue balls). (B)
Schematic model illustrating the location of the two cholesterol binding
regions along with labeling of the channel regions. Note that for clarity
purposes, the model shows the cholesterol molecules next to one of the
two adjacent channel subunits with which they are predicted to interact.
From Rosenhouse-Dantsker et al. (2013).
and the channel residues, and surface area effects due to expul-
sion of solvent molecules from hydrophobic surfaces. In addition,
the binding affinity and stability of cholesterol to the channel
can be assessed by determining the equilibrium free energy of
the process that is composed of two thermodynamic compo-
nents, the binding enthalpy described above and the binding
entropy. Combining the contributions of the binding enthalpy
and entropy, our calculations indicated that the equilibrium free
energy was favorable in region 1 and unfavorable in region 2
(Rosenhouse-Dantsker et al., 2013). Yet, in view of the small abso-
lute value of the free energy in region 1, the binding affinity of
cholesterol to this region is expected to be weak. Furthermore,
despite the unfavorable equilibrium free energy of cholesterol
binding to region 2, we cannot rule out the possibility of weak
cholesterol binding to region 2 as well because of its small abso-
lute value and of the typical standard error. Thus, both regions
may form cholesterolophilic surfaces with a preference for bind-
ing region 1, which is located in the center of the transmembrane
domain. Since mutations of both regions abrogated the sensitivity
of the channels to cholesterol, region 2 may represent a transient
site with weak and possibly short-lived cholesterol binding, which
is nevertheless necessary for cholesterol to have an effect on chan-
nel function. It is possible that transient binding to the interface
region is necessary for cholesterol to access a more stable binding
region in the TM domain (Rosenhouse-Dantsker et al., 2013).
Implications for channel modulation by cholesterol
Both putative cholesterol binding pockets are located in regions
that have been previously shown to play critical roles in the gat-
ing mechanism of Kir channels (Figure 5). Cholesterol-binding
region 1 at the center of the transmembrane domain overlaps
with the hinge region of the inner helix of the channel (Jiang
et al., 2002; Jin et al., 2002; Rosenhouse-Dantsker and Logothetis,
2006). The flexibility of this region is required for ensuring the
frequent gating of the helix bundle crossing of the channel. It is
therefore possible that cholesterol binding may interfere with the
hinging motion of the inner helix stabilizing the channel in the
closed state. In region 2, cholesterol connects between the slide
helix of the N-terminus and the C-linker that connects the C-
terminus and the inner transmembrane helix. The interactions
between the N- and C- termini have been suggested to provide a
tangential force that mechanically gates the channel (Logothetis
et al., 2007). Accordingly, interactions between cholesterol and
residues located in region 2 may affect the gating mechanism that
leads to the opening of the inner helix gate while bending the
pore-lining helix at the central glycine hinge. These mechanisms
may extend to other ion channels. It has been proposed that a
flexible gating hinge in the middle of the inner helix is a common
feature in 80% of potassium and cyclic nucleotide-gated chan-
nels (Jin et al., 2002). Therefore, if cholesterol binds to the region
immediately adjacent to this gating hinge, it may interfere with
the hinging motion of the inner helix during channel gating in
multiple channels.
SUMMARY AND CONCLUSIONS
Comparative analysis of sterol effects on different types of
ion channels provide growing evidence that multiple chan-
nels are regulated primarily by specific sterol-protein inter-
actions rather than by changes in the physical properties of
the membrane bilayer. Our earlier studies demonstrated the
www.frontiersin.org February 2014 | Volume 5 | Article 65 | 11
Levitan et al. Cholesterol as a ligand of ion channels
stereospecificity of cholesterol effects on Kir channels in endothe-
lial cells (Romanenko et al., 2002), which was further confirmed
for KirBac channels (Singh et al., 2009) and for purified Kir2.1
channels (D’Avanzo et al., 2010). More recently, cholesterol stere-
ospecificity demonstrated for BK channels (Bukiya et al., 2011)
and TRPV1 channels (Picazo-Juarez et al., 2011). Moreover, these
observations are consistent with earlier studies in nAChR show-
ing that even though the effect of cholesterol is not stereospecific,
it is sensitive to specific sterol substitutions. It is important to note
that specific sterol-protein interactions may underlie both the
inhibitory (Kir, BK, TRPV1) and the facilitatory effects (nAChR)
of cholesterol (Barrantes, 2007; Levitan et al., 2010; Rosenhouse-
Dantsker et al., 2012a). In contrast, an example of a mammalian
ion channel that has been demonstrated not to be sensitive to
specific sterols but rather to lipid packing is VRAC (Romanenko
et al., 2004b). Clearly though only a handful of ion channels has
been analyzed so far and more work is needed to systematically
test different ion channel families. Another major advance in the
field is demonstration of binding of cholesterol to an ion channel
(KirBac) that provided direct evidence for binding of cholesterol
to a purified ion channel.
Significant new insights have also been obtained in elucidat-
ing the structural requirements of cholesterol interaction with ion
channels. Known cholesterol-binding motifs, CRAC and CARC,
have been identified in several types of ion channels (BK, nAChR,
and Kir2.1) (Singh et al., 2012; Fantini and Barrantes, 2013;
Rosenhouse-Dantsker et al., 2013). Interestingly, it was pro-
posed that among these two motifs, the inverted CRAC motif,
CARC may be more energetically beneficial for cholesterol-ion
channels interactions (Fantini and Barrantes, 2013). The most
extensive site-directed mutagenesis studies so far have been con-
ducted in Kir2.1 channels where numerous mutations in both
cytoplasmic (Epshtein et al., 2009; Rosenhouse-Dantsker et al.,
2011, 2012b, 2013) and transmembrane domains (Epshtein et al.,
2009; Rosenhouse-Dantsker et al., 2011, 2012b, 2013) of the
channels provided insight into the molecular mechanisms of
cholesterol regulation of these channels. Moreover, recent stud-
ies of Kir2.1 revealed two putative cholesterol binding regions
at non-annular sites of the transmembrane domain (Epshtein
et al., 2009; Rosenhouse-Dantsker et al., 2011, 2012b, 2013).
These cholesterol binding sites define three-dimensional bind-
ing surfaces that cannot be described by a motif that only
includes one simple continuous sequence such as the CRAC or
CARC motifs. This notion that cholesterol binds to transmem-
brane proteins in between several α-helices within the trans-
membrane domain is further supported by the similar char-
acteristics of the binding sites that were identified in several
types of GPCRs such as the β-adrenergic receptor (Cherezov
et al., 2007; Hanson et al., 2008) and the dopamine receptor
(Penmatsa et al., 2013). Similarly to the case in Kir2.1, also
in these two transmembrane proteins primarily hydrophobic
residues formed cholesterol binding sites in between α-helices
of the transmembrane domain. It is also important to note that
while several residues have also been found to decrease or abro-
gate cholesterol sensitivity of Kir2.1 in the cytosolic domain of
the channels, these sites are not expected to constitute choles-
terol binding sites. Thus, residues that affect cholesterol sensitivity
of the channels may not necessarily be part of a binding site
and it is necessary to discriminate between direct and indi-
rect effects of specific mutations. This can be achieved by a
combination of computational studies and measuring direct
binding.
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